These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 15694197

  • 21. AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance.
    Donofrio PD, Kelly JJ.
    Muscle Nerve; 1989 Jan; 12(1):1-8. PubMed ID: 2546074
    [Abstract] [Full Text] [Related]

  • 22. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, Klein CJ.
    Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
    [Abstract] [Full Text] [Related]

  • 23. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L, Kaboré R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM.
    J Immunol Res; 2015 Apr; 2015():450391. PubMed ID: 26065001
    [Abstract] [Full Text] [Related]

  • 24. Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
    Vrethem M, Reiser N, Lauermann C, Svanborg E.
    Acta Neurol Scand; 2010 Jul; 122(1):52-7. PubMed ID: 20003083
    [Abstract] [Full Text] [Related]

  • 25. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
    Leger JM, Vaunaize J.
    Nouv Rev Fr Hematol (1978); 1990 Jul; 32(5):303-6. PubMed ID: 1965990
    [Abstract] [Full Text] [Related]

  • 26. [Peripheral neuropathies associated with IgM monoclonal gammopathy: clinical and electrophysiological aspects].
    Léger JM, Chassande B, Bouche P.
    Rev Neurol (Paris); 1996 May; 152(5):394-9. PubMed ID: 8881438
    [Abstract] [Full Text] [Related]

  • 27. Chronic idiopathic ataxic neuropathy.
    Dalakas MC.
    Ann Neurol; 1986 Jun; 19(6):545-54. PubMed ID: 3014995
    [Abstract] [Full Text] [Related]

  • 28. [Peripheral neuropathy with monoclonal gammopathy].
    Meier T, Meyer M.
    Schweiz Med Wochenschr; 1990 Mar 24; 120(12):417-25. PubMed ID: 2157280
    [Abstract] [Full Text] [Related]

  • 29. [Fatal peripheral neuropathy with predominant motor involvement associated with anti-MAG IgM monoclonal gammapathy].
    Antoine JC, Steck A, Michel D.
    Rev Neurol (Paris); 1993 Mar 24; 149(8-9):496-9. PubMed ID: 7516570
    [Abstract] [Full Text] [Related]

  • 30. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N.
    Ann Neurol; 1995 May 24; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [Abstract] [Full Text] [Related]

  • 31. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
    Mehndiratta MM, Sen K, Tatke M, Bajaj BK.
    J Neurol Sci; 2004 Jun 15; 221(1-2):99-104. PubMed ID: 15178222
    [Abstract] [Full Text] [Related]

  • 32. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, Bouche P, Musset L, Fournier E, Léger JM.
    Eur J Neurol; 2011 Jun 15; 18(6):899-905. PubMed ID: 21199182
    [Abstract] [Full Text] [Related]

  • 33. [The neuropathies of IgM monoclonal gammopathies].
    Humbel RL, Schmit P, Gilson G.
    Bull Soc Sci Med Grand Duche Luxemb; 1997 Jun 15; 134(2):11-5. PubMed ID: 9534268
    [Abstract] [Full Text] [Related]

  • 34. [Dysglobulinemic neuropathies].
    Gherardi R, Zuber M, Viard JP.
    Rev Neurol (Paris); 1988 Jun 15; 144(6-7):391-408. PubMed ID: 2847276
    [Abstract] [Full Text] [Related]

  • 35. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
    Gruson B, Ghomari K, Beaumont M, Garidi R, Just A, Merle P, Merlusca L, Marolleau JP, Royer B.
    J Peripher Nerv Syst; 2011 Sep 15; 16(3):180-5. PubMed ID: 22003932
    [Abstract] [Full Text] [Related]

  • 36. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC.
    Neurology; 2010 Feb 02; 74(5):406-12. PubMed ID: 20124206
    [Abstract] [Full Text] [Related]

  • 37. Length dependence in polyneuropathy associated with IgM gammopathy.
    Franssen H, Notermans NC.
    Ann Neurol; 2006 Feb 02; 59(2):365-71. PubMed ID: 16437567
    [Abstract] [Full Text] [Related]

  • 38. Neuropathy and monoclonal gammopathy.
    Nobile-Orazio E.
    Handb Clin Neurol; 2013 Feb 02; 115():443-59. PubMed ID: 23931795
    [Abstract] [Full Text] [Related]

  • 39. Peripheral neuropathy and anti-MAG antibodies.
    Latov N, Hays AP, Sherman WH.
    Crit Rev Neurobiol; 1988 Feb 02; 3(4):301-32. PubMed ID: 2458847
    [Abstract] [Full Text] [Related]

  • 40. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology.
    Goldfarb AR, Latov N, Brannagan TH, Chin RL, de Sousa EA, Sander HW.
    Neurol Neurophysiol Neurosci; 2006 Dec 22; ():7. PubMed ID: 17260084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.